208 related articles for article (PubMed ID: 15545183)
1. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
Acta Oncol; 2004; 43(7):626-36. PubMed ID: 15545183
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
[TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
[No Abstract] [Full Text] [Related]
6. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
[TBL] [Abstract][Full Text] [Related]
7. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing-peptide in neuroendorine tumours.
Granberg D; Skogseid B; Welin S; Orlefors H; Oberg K; Wilander E
Acta Oncol; 2006; 45(1):23-7. PubMed ID: 16464792
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors.
Kamp K; Alwani RA; Korpershoek E; Franssen GJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2016 Mar; 174(3):271-80. PubMed ID: 26643855
[TBL] [Abstract][Full Text] [Related]
11. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
Rindi G; Capella C; Solcia E
Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
[TBL] [Abstract][Full Text] [Related]
12. CT/MRI of neuroendocrine tumours.
Reznek RH
Cancer Imaging; 2006 Oct; 6(Spec No A):S163-77. PubMed ID: 17114072
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
14. New and emerging syndromes due to neuroendocrine tumors.
Vinik AI; Gonzales MR
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):19-63, vii. PubMed ID: 21349410
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET).
Kanakis G; Kamp K; Tsiveriotis K; Feelders RA; Zormpala A; de Herder WW; Kaltsas G
Clin Endocrinol (Oxf); 2013 Jun; 78(6):950-6. PubMed ID: 22970733
[TBL] [Abstract][Full Text] [Related]
17. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
Tsimmerman IaS
Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
[TBL] [Abstract][Full Text] [Related]
18. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
20. Tumour biology and histopathology of neuroendocrine tumours.
Klöppel G
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
